Cargando…
Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China
BACKGROUND AND PURPOSE: With the progressive increase in the prevalence of type 2 diabetes mellitus (T2DM), diabetic nephropathy (DN) – one of the most common chronic microvascular complications – has evolved into a significant cause of death worldwide among end-stage renal disease patients. Academi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490461/ https://www.ncbi.nlm.nih.gov/pubmed/36157308 http://dx.doi.org/10.1177/20420188221118750 |
_version_ | 1784793090179989504 |
---|---|
author | Liu, Yazhuo Li, Yingying Shen, Hui Li, Yike Xu, Yanbing Zhou, Mi Xia, Xinghai Shi, Binyin |
author_facet | Liu, Yazhuo Li, Yingying Shen, Hui Li, Yike Xu, Yanbing Zhou, Mi Xia, Xinghai Shi, Binyin |
author_sort | Liu, Yazhuo |
collection | PubMed |
description | BACKGROUND AND PURPOSE: With the progressive increase in the prevalence of type 2 diabetes mellitus (T2DM), diabetic nephropathy (DN) – one of the most common chronic microvascular complications – has evolved into a significant cause of death worldwide among end-stage renal disease patients. Academic researchers have for decades focused on the development of DN and recently found that free fatty acids (FFAs) constituted an independent risk factor for vascular complications in T2DM patients. It is therefore critical to determine whether the metabolic profile of FFAs is related to DN. METHODS: This study comprised 611 research subjects in Dalian, a city in northeast China: 52 DN patients, 115 T2DM patients, and 444 healthy controls. We determined 15 forms of serum FFAs, including arachidonic acid (AA, C20:4), docosahexaenoic acid (DHA, C22:6), erucic acid (C22:1), nervonic acid (NA, C24:1), estimated total omega-3s, total omega-6s, the omega-3/omega-6 ratio, and total FFA content by liquid chromatography–mass spectrometry (LC-MS). RESULTS: The levels of NA (mean = 45.27, range = 0.84–76.57) and DHA (mean = 324.58, range = 205.38–450.03) in DN patients were slightly lower than those in T2DM patients or healthy controls. The serum omega-3 polyunsaturated fatty acid (PUFA) DHA (C22:6) was significantly negatively correlated with microalbuminuria (MAU), the albumin/creatinine ratio (ACR), body mass index (BMI), fasting plasma glucose (FPG), and glycosylated hemoglobin (HbA1c). The serum monounsaturated fatty acid (MUFA) NA (C24:1) was significantly negatively correlated with BMI, FPG, and HbA1c. After adjustment of variables, multiple logistic regression analysis revealed significant odds ratios (ORs) [with confidence intervals (CIs)] for DHA (0.991, 0.985–0.997; p = 0.002) and NA (0.978, 0.958–0.999; p = 0.037). CONCLUSION: In this study, we ascertained that the contents of NA and DHA in patients with DN were relatively low, and that DHA was negatively correlated with MAU and the ACR. However, large-scale, population-based studies focusing on the role of NA and DHA in the pathogenesis of DN are still required in the future. |
format | Online Article Text |
id | pubmed-9490461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-94904612022-09-22 Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China Liu, Yazhuo Li, Yingying Shen, Hui Li, Yike Xu, Yanbing Zhou, Mi Xia, Xinghai Shi, Binyin Ther Adv Endocrinol Metab Diabetic Kidney Disease: Pathogenesis and Therapeutic Targets BACKGROUND AND PURPOSE: With the progressive increase in the prevalence of type 2 diabetes mellitus (T2DM), diabetic nephropathy (DN) – one of the most common chronic microvascular complications – has evolved into a significant cause of death worldwide among end-stage renal disease patients. Academic researchers have for decades focused on the development of DN and recently found that free fatty acids (FFAs) constituted an independent risk factor for vascular complications in T2DM patients. It is therefore critical to determine whether the metabolic profile of FFAs is related to DN. METHODS: This study comprised 611 research subjects in Dalian, a city in northeast China: 52 DN patients, 115 T2DM patients, and 444 healthy controls. We determined 15 forms of serum FFAs, including arachidonic acid (AA, C20:4), docosahexaenoic acid (DHA, C22:6), erucic acid (C22:1), nervonic acid (NA, C24:1), estimated total omega-3s, total omega-6s, the omega-3/omega-6 ratio, and total FFA content by liquid chromatography–mass spectrometry (LC-MS). RESULTS: The levels of NA (mean = 45.27, range = 0.84–76.57) and DHA (mean = 324.58, range = 205.38–450.03) in DN patients were slightly lower than those in T2DM patients or healthy controls. The serum omega-3 polyunsaturated fatty acid (PUFA) DHA (C22:6) was significantly negatively correlated with microalbuminuria (MAU), the albumin/creatinine ratio (ACR), body mass index (BMI), fasting plasma glucose (FPG), and glycosylated hemoglobin (HbA1c). The serum monounsaturated fatty acid (MUFA) NA (C24:1) was significantly negatively correlated with BMI, FPG, and HbA1c. After adjustment of variables, multiple logistic regression analysis revealed significant odds ratios (ORs) [with confidence intervals (CIs)] for DHA (0.991, 0.985–0.997; p = 0.002) and NA (0.978, 0.958–0.999; p = 0.037). CONCLUSION: In this study, we ascertained that the contents of NA and DHA in patients with DN were relatively low, and that DHA was negatively correlated with MAU and the ACR. However, large-scale, population-based studies focusing on the role of NA and DHA in the pathogenesis of DN are still required in the future. SAGE Publications 2022-09-16 /pmc/articles/PMC9490461/ /pubmed/36157308 http://dx.doi.org/10.1177/20420188221118750 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Diabetic Kidney Disease: Pathogenesis and Therapeutic Targets Liu, Yazhuo Li, Yingying Shen, Hui Li, Yike Xu, Yanbing Zhou, Mi Xia, Xinghai Shi, Binyin Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China |
title | Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China |
title_full | Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China |
title_fullStr | Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China |
title_full_unstemmed | Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China |
title_short | Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China |
title_sort | association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern china |
topic | Diabetic Kidney Disease: Pathogenesis and Therapeutic Targets |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490461/ https://www.ncbi.nlm.nih.gov/pubmed/36157308 http://dx.doi.org/10.1177/20420188221118750 |
work_keys_str_mv | AT liuyazhuo associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina AT liyingying associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina AT shenhui associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina AT liyike associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina AT xuyanbing associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina AT zhoumi associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina AT xiaxinghai associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina AT shibinyin associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina |